Bio-Rad Laboratories, Inc. is a healthcare company.
Bio-Rad Laboratories, Inc. (BIO) is expected to report earnings on Wednesday, November 4, 2026, after the close. Estimated release time 16:17 ET. Consensus EPS estimate is $2.23.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-04-30 | Mar 2026 qtr | $1.97 | $1.89 | -4.1% | $592.10M |
| 2025-10-29 | Sep 2025 qtr | $2.30 | $2.26 | -1.7% | $653.00M |
| 2025-05-01 | Mar 2025 qtr | $1.73 | $2.29 | — | $585.40M |
| 2025-02-14 | Dec 2024 qtr | $2.86 | $2.90 | +1.4% | $667.48M |
| 2024-08-02 | Jun 2024 qtr | $2.12 | $3.11 | — | $638.48M |
| 2023-10-27 | Sep 2023 qtr | $2.87 | $3.65 | — | $632.12M |
| 2023-08-04 | Jun 2023 qtr | $2.55 | $3.00 | — | $681.11M |
| 2023-05-05 | Mar 2023 qtr | $3.24 | $2.33 | — | $676.84M |
BIO has beaten consensus EPS in 1 of its last 3 scored quarters.
See BIO on the live calendar →